Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma

PURPOSE: The purpose of this study was to better understand the efficacy and safety of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma(R/RMM). METHODS: We retrieved and reviewed published reports including carfilzomib, panobinostat, and el...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liping, Zhao, Ningning, Xu, Wenjun, Sheng, Zhixin, Wang, Lida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941034/
https://www.ncbi.nlm.nih.gov/pubmed/27405295
http://dx.doi.org/10.1186/s13045-016-0286-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941034/
https://www.ncbi.nlm.nih.gov/pubmed/27405295
http://dx.doi.org/10.1186/s13045-016-0286-x

Ejemplares similares